Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101494703 | 10149470 | 3 | F | 20130709 | 20150616 | 20140430 | 20150630 | EXP | US-000919 | NPS | 53.84 | YR | M | N | 0.00000 | 20150629 | N | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101494703 | 10149470 | 1 | PS | GATTEX | TEDUGLUTIDEWATER | 1 | Subcutaneous | 0.32 ML QD, STREN/VOLUM: 0.32ML/FREQU: ONCE A DAY SUBCUTANEOUS) | AV13219AA | 203441 | 0.32 | ML | QD | ||||||
| 101494703 | 10149470 | 3 | C | HUMIRA | ADALIMUMAB | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 5 | C | PROGRAFT | TACROLIMUS | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 7 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 9 | C | CITRACAL | CALCIUM CITRATE | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 13 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 15 | C | ENTOCORT EC | BUDESONIDE | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 17 | C | LACTATED RINGERS | CALCIUM CHLORIDEPOTASSIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 19 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 21 | C | MULTIVITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 23 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 | ||||||||||||
| 101494703 | 10149470 | 25 | C | SOLUTIONS FOR PARENTERAL NUTRITION | AMINO ACIDSDEXTROSEELECTROLYTES NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101494703 | 10149470 | 1 | Short-bowel syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101494703 | 10149470 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101494703 | 10149470 | Dysgeusia | |
| 101494703 | 10149470 | Flatulence | |
| 101494703 | 10149470 | Injection site urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 101494703 | 10149470 | HP |
| 101494703 | 10149470 | CSM |
| 101494703 | 10149470 | CR |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101494703 | 10149470 | 1 | 20130709 | 0 |